Treating your Skin cancer - pt -update
•Download as PPTX, PDF•
0 likes•126 views
This document discusses skin cancers like basal cell carcinoma, squamous cell carcinoma, and melanoma in situ. It provides quick facts about each type of cancer, including prevalence, risk of metastasis, and treatment options. It emphasizes that Mohs micrographic surgery (Mohs) offers the highest certainty of removal with minimal tissue sacrifice, especially for tumors in vital areas. The document also describes the author's miMOHS technique which aims to create a comfortable experience for patients undergoing Mohs surgery.
Report
Share
Report
Share
Recommended
Grand rounds 8 4-2011
The document discusses early diagnosis and treatment of various skin tumors and lesions. It provides details on characteristics of pigmented lesions and different types of skin cancer like basal cell carcinoma, melanoma, and dermatofibrosarcoma protuberans. Guidelines are presented on evaluating skin lesions, determining appropriate excision margins based on histology and location, and managing cases of positive margins. The importance of discussing treatment plans with patients and documenting decisions is also emphasized.
Malignant melanoma
Dr. Travers gave this brief talk to the Melanoma Foundation's "Running for Cover" Boston Marathon team on Nov 16.
Mailgnant melanoma
This document provides an overview of melanoma, including its causes, risk factors, types, diagnosis, staging, and treatment. It discusses that melanoma arises from melanocytes, can spread from the skin to other organs, and accounts for the majority of skin cancer deaths. Early detection through changes in moles is important for improved prognosis, as thickness and spread determine survival rates. Surgical removal is the main treatment, and sentinel lymph node biopsy helps determine if it has spread to lymph nodes.
Melanoma update
The document discusses recommendations from ASCO for sentinel lymph node biopsy and management of regional lymph nodes in melanoma patients. It recommends that SLN biopsy is not needed for thin melanomas less than 0.8mm thick without ulceration. SLN biopsy may be considered for lesions between 0.8-1mm thick or less than 0.8mm thick with ulceration after discussing risks and benefits with the patient. SLN biopsy is also recommended for thick melanomas over 4mm thick after discussing risks and benefits. If the SLN biopsy is positive, completing lymph node dissection is an option.
Malignant Melanoma
Malignant melanoma incidence has been increasing 6% per year, making it one of the fastest growing cancers. Early diagnosis through thorough examination and surgical removal of the tumor are the most important treatment methods. Survival rates have increased from 50% in 1960 to 80% in 1990 due to earlier detection and treatment. Risk factors include fair skin, sun exposure, and genetic conditions.
Malignant Melanoma
Malignant melanoma diagnosis and management has advanced recently. Melanoma arises from melanocytes and can affect the skin, eyes, or internal organs. Recent trends include more accurate staging using tumor thickness, ulceration, and mitosis rate rather than Clark's level. Sentinel lymph node biopsy helps stage intermediate thickness melanomas. For advanced cases, targeted therapies like BRAF inhibitors and immunotherapies have improved outcomes. Wide local excision remains the main surgical treatment, with reconstruction to optimize function and allow adjuvant therapies. Long-term follow-up is important due to the risk of late recurrence.
Melanoma video slides
Malignant melanoma begins in melanocytes in the epidermis and is becoming more common, rising 3% per year. It accounts for about 2-4% of skin cancers. Risk factors include sun exposure and fair skin. Early stage melanoma is treated with wide local excision, while more advanced cases may also require sentinel node biopsy. Treatment of metastatic melanoma has advanced significantly with targeted therapies blocking oncogenic pathways like BRAF and immunotherapies disrupting checkpoints like CTLA-4. Long term survival depends on factors like depth of invasion and ulceration.
T pousse mistakes and pitfalls in breast cancers jfim hanoi 2015
T pousse mistakes and pitfalls in breast cancers jfim hanoi 2015JFIM - Journées Francophones d'Imagerie Médicale
1) Interval cancers occur between mammography screenings and can be missed due to limitations in mammography detection or characterization. The rate of missed interval cancers is reported between 7.5 to 22 per 10,000 mammograms.
2) Factors that can contribute to missed cancers include breast density, small lesion size, subtle appearance, and improper characterization. Retrospective reviews often find lesions that were visible but not properly characterized on prior mammograms.
3) Newer digital mammography techniques like digital breast tomosynthesis have been shown to improve detection and characterization compared to full field digital mammography alone, especially for women under 50 and those with dense breasts. Larger studies are still needed to fully evaluate performance.Recommended
Grand rounds 8 4-2011
The document discusses early diagnosis and treatment of various skin tumors and lesions. It provides details on characteristics of pigmented lesions and different types of skin cancer like basal cell carcinoma, melanoma, and dermatofibrosarcoma protuberans. Guidelines are presented on evaluating skin lesions, determining appropriate excision margins based on histology and location, and managing cases of positive margins. The importance of discussing treatment plans with patients and documenting decisions is also emphasized.
Malignant melanoma
Dr. Travers gave this brief talk to the Melanoma Foundation's "Running for Cover" Boston Marathon team on Nov 16.
Mailgnant melanoma
This document provides an overview of melanoma, including its causes, risk factors, types, diagnosis, staging, and treatment. It discusses that melanoma arises from melanocytes, can spread from the skin to other organs, and accounts for the majority of skin cancer deaths. Early detection through changes in moles is important for improved prognosis, as thickness and spread determine survival rates. Surgical removal is the main treatment, and sentinel lymph node biopsy helps determine if it has spread to lymph nodes.
Melanoma update
The document discusses recommendations from ASCO for sentinel lymph node biopsy and management of regional lymph nodes in melanoma patients. It recommends that SLN biopsy is not needed for thin melanomas less than 0.8mm thick without ulceration. SLN biopsy may be considered for lesions between 0.8-1mm thick or less than 0.8mm thick with ulceration after discussing risks and benefits with the patient. SLN biopsy is also recommended for thick melanomas over 4mm thick after discussing risks and benefits. If the SLN biopsy is positive, completing lymph node dissection is an option.
Malignant Melanoma
Malignant melanoma incidence has been increasing 6% per year, making it one of the fastest growing cancers. Early diagnosis through thorough examination and surgical removal of the tumor are the most important treatment methods. Survival rates have increased from 50% in 1960 to 80% in 1990 due to earlier detection and treatment. Risk factors include fair skin, sun exposure, and genetic conditions.
Malignant Melanoma
Malignant melanoma diagnosis and management has advanced recently. Melanoma arises from melanocytes and can affect the skin, eyes, or internal organs. Recent trends include more accurate staging using tumor thickness, ulceration, and mitosis rate rather than Clark's level. Sentinel lymph node biopsy helps stage intermediate thickness melanomas. For advanced cases, targeted therapies like BRAF inhibitors and immunotherapies have improved outcomes. Wide local excision remains the main surgical treatment, with reconstruction to optimize function and allow adjuvant therapies. Long-term follow-up is important due to the risk of late recurrence.
Melanoma video slides
Malignant melanoma begins in melanocytes in the epidermis and is becoming more common, rising 3% per year. It accounts for about 2-4% of skin cancers. Risk factors include sun exposure and fair skin. Early stage melanoma is treated with wide local excision, while more advanced cases may also require sentinel node biopsy. Treatment of metastatic melanoma has advanced significantly with targeted therapies blocking oncogenic pathways like BRAF and immunotherapies disrupting checkpoints like CTLA-4. Long term survival depends on factors like depth of invasion and ulceration.
T pousse mistakes and pitfalls in breast cancers jfim hanoi 2015
T pousse mistakes and pitfalls in breast cancers jfim hanoi 2015JFIM - Journées Francophones d'Imagerie Médicale
1) Interval cancers occur between mammography screenings and can be missed due to limitations in mammography detection or characterization. The rate of missed interval cancers is reported between 7.5 to 22 per 10,000 mammograms.
2) Factors that can contribute to missed cancers include breast density, small lesion size, subtle appearance, and improper characterization. Retrospective reviews often find lesions that were visible but not properly characterized on prior mammograms.
3) Newer digital mammography techniques like digital breast tomosynthesis have been shown to improve detection and characterization compared to full field digital mammography alone, especially for women under 50 and those with dense breasts. Larger studies are still needed to fully evaluate performance.Skin Cancer
Property of Prof. Dr. Mohamed Ali Nasr, Department of General Surgery, Faculty of Medicine, University of Zagazig, Egypt
Melanoma
This document provides information on malignant melanoma. Some key points:
- Melanoma is a malignancy of melanocytes that can occur in skin, eyes, and mucous membranes. It has a high ability to metastasize to other organs.
- Incidence is increasing worldwide. Risk factors include fair skin, moles, UV exposure, and family history.
- Diagnosis involves examining lesions for characteristics like asymmetry, irregular borders, varied color, and size over 6mm. Biopsies are used to confirm.
- Staging uses the TNM system and considers tumor thickness, ulceration, and lymph node/distant organ involvement. Prognosis depends on stage - thicker tumors over 2mm
Melanoma presentation
Melanoma is the sixth most common cancer in the US, with 68,000 new cases diagnosed each year and 8,700 annual deaths. Risk factors include fair skin, light eyes, family history, and sun exposure. Melanoma has been recognized as a disease since 1806 and stages range from Stage 0 precancerous lesions to Stage IV metastatic cancer. Treatment options depend on the stage and may include surgery, radiation, immunotherapy, and experimental therapies.
Melanoma
Melanoma is the most serious type of skin cancer. Often the first sign of melanoma is a change in the size, shape, color or feel of a mole. Most melanomas have a black or black-blue area. Melanoma may also appear as a new mole. It may be black, abnormal or "ugly looking."
Thinking of "ABCD" can help you remember what to watch for:
Asymmetry - the shape of one half does not match the other
Border - the edges are ragged, blurred or irregular
Color - the color is uneven and may include shades of black, brown and tan
Diameter - there is a change in size, usually an increase
Melanoma can be cured if it is diagnosed and treated early. If melanoma is not removed in its early stages, cancer cells may grow downward from the skin surface and invade healthy tissue. If it spreads to other parts of the body it can be difficult to control.
Melanoma
This document discusses melanoma, the most fatal form of skin cancer. It covers the incidence and risk factors of melanoma including genetics, sun exposure, and skin phenotype. The clinical features and subtypes of melanoma like superficial spreading, nodular, lentigo maligna, and acral lentiginous melanoma are described. Diagnosis involves methods like the ABCDE rule and biopsy for suspicious lesions. Staging uses the TNM system and prognostic factors include tumor thickness and mitotic rate. Management involves wide local excision of primary tumors and sentinel lymph node biopsy for involved nodes. Long term surveillance after treatment monitors for recurrence.
4part2
This document summarizes diagnosis and management of various skin cancers and pigmented lesions. It discusses diagnosis and treatment options for basal cell carcinoma, squamous cell carcinoma, melanoma, and other skin tumors. Photodynamic therapy is described as an 80% effective treatment for superficial basal cell carcinoma. Metastatic rates for squamous cell carcinoma are provided based on literature reviews. Risk factors and treatment guidelines are outlined for melanoma depending on depth of invasion and presence of metastases. Differential diagnoses are also reviewed for problematic pigmented lesions and melanomas.
Melanoma Prevention, Screening and Diagnosis - Dr. Ana Ciurea
Dr. Ana Ciurea presents the basics of melanoma preventio, screening and diagnosis at the MRF's Patient Symposium at MD Anderson Cancer Center on January 31, 2015.
Melanoma: how to detect skin cancer
Simple and fast way to detect skin cancer, melanoma.
What is cancer? Types of skin cancer, the ABCDE rule, treatment, preventing. by Daniel Lopes
Melanoma sign symptom management surgery prevention ملانوم
Melanoma sign symptom management surgery prevention ملانوم
درمان
جراحی
پیشگیری
پوست
تابش آفتاب
sun exposure
Melanoma
This document summarizes melanoma, a type of skin cancer. It originates from melanocytes in the skin or mucosal surfaces. Melanoma is more common and dangerous in white people and younger women. The main risk factor is ultraviolet radiation from the sun or tanning beds. There are four main types of melanoma named after their appearance or location on the skin. Doctors diagnose melanoma through history, physical exam, and biopsy. It is staged based on how deep it has penetrated the skin and if it has spread. Treatment options range from surgery for early stages to immunotherapy and chemotherapy for later stages.
Melanoma
- Melanoma is a malignant tumor arising from melanocytes that produces melanin. It is more common in whites due to higher UV exposure and occurs most often on head/neck, trunk and limbs. Risk factors include fair skin, moles, family history and sun exposure.
- There are several clinical types including superficial spreading, nodular, lentigo maligna, acral and amelanotic melanomas. Staging uses Breslow thickness, Clark levels, and TNM classification. Diagnosis involves biopsy and imaging tests.
- Treatment depends on stage and includes surgery, lymph node dissection, chemotherapy, immunotherapy and radiation. Prognosis is best for early stage disease and worse for advanced stages
Melanoma
This document provides information about melanoma, a serious type of skin cancer. It defines melanoma as cancer of the melanocytes, which are cells that produce skin pigment. Risk factors include family history, many moles, sunburn, and fair skin. Signs include changes in existing moles or new abnormal growths. The stages are described from earliest (stage 0) to latest (stage IV), with treatment options at each stage. Prevention focuses on sun protection and avoiding sun exposure when UV rays are strongest.
Melanoma
This document summarizes key information about melanoma. It discusses the increasing incidence rates of melanoma and describes the different types, including superficial spreading, nodular, lentigo maligna, and acral lentiginous. Prognostic factors like Breslow thickness, ulceration, location, and gender are covered. Treatment options are outlined, including surgical excision for early-stage melanoma and immunotherapy or chemotherapy for advanced or metastatic disease. Future treatments under investigation include vaccines, monoclonal antibodies, and radiation therapy.
Oral cancer
This document summarizes key information about oral cancer:
1) Oral cancer is a major malignancy in the Indian subcontinent, affecting males over 60 years old at a higher rate. Risk factors include smoking, alcohol, betel nut and spice chewing.
2) Premalignant lesions like leukoplakia and erythroplakia are associated with increased risk of oral cancer. Conditions like submucous fibrosis from betel chewing can also progress to oral squamous cell carcinoma.
3) Patient workup for oral cancer involves history, clinical exam, biopsy or FNAC of suspicious lesions, and imaging tests. Staging follows AJCC guidelines and helps determine prognosis and guide treatment.
Melanoma
Melanoma is the 5th and 6th most common malignancy in men and women respectively. It accounts for a disproportionate number of skin cancer deaths. Risk factors include family history, fair skin, intermittent sun exposure, and dysplastic nevi. Melanomas arise from melanocytes and can present in different clinical subtypes depending on their location and growth pattern. Prognosis depends on tumor thickness, ulceration status, mitotic rate, and presence of metastases. Treatment involves surgical excision with margins and possible lymph node evaluation and adjuvant therapy for advanced cases. Lifelong surveillance is important due to the risk of recurrence even decades later.
Melanoma
Melanoma is a malignant skin cancer that develops from pigment-producing cells called melanocytes. It accounts for only 1% of skin cancers but causes the majority of skin cancer deaths. Risk factors include sun exposure, the use of tanning beds, and family history. Genetic mutations in genes like BRAF, NRAS, and CDKN2A contribute to melanoma development and progression. Different types of melanoma exist including superficial spreading, nodular, lentigo maligna, acral lentiginous, and ocular/mucosal melanoma. Staging uses the Clark level and Breslow thickness scales. Treatment depends on stage but may include surgery, immunotherapy, targeted therapy, and chemotherapy. Prevention involves sun protection
Malignant melanoma
Melanoma is a serious form of skin cancer that arises in melanocytes, which are skin cells that produce melanin. It is caused by exposure to UV radiation from the sun in most cases. There are several stages of melanoma based on how deep it has penetrated the skin and whether it has spread to lymph nodes or distant organs. Early stage melanoma can usually be cured with surgery, while later stages may require additional treatments like chemotherapy. Prevention through sun protection and skin self-examinations is important to detect melanoma early.
Fwd: Skin Cancer (Cormac Joyce)
---------- Forwarded message ----------
From: UCD Graduate '09 None <ucdgrad09@gmail.com>
Date: 2009/2/25
Subject: Skin Cancer (Cormac Joyce)
To: ucdgrad09@gmail.com
Squamous cell carcinoma
Squamous cell carcinoma (SCC) is a type of skin cancer that develops in squamous cells, which make up the outer layer of the skin. SCCs often appear as scaly red patches or elevated growths and are caused by cumulative lifetime sun exposure. Risk factors include light skin, age, male gender, and sun or chemical exposure. SCCs are most common on sun-exposed areas like the face and neck and are usually treated by removing the lesion, though advanced cases may require surgery, radiation, or chemotherapy. Maintaining good oral hygiene is important for preventing complications from oral SCCs and their treatment.
Melanoma1
This document discusses melanoma, including risk factors like sun exposure and tanning beds. It covers the staging of melanoma from Stage 0 to Stage 4 and treatments that may be used like surgery, sentinel node biopsy, interferon, Yervoy, and Zelboraf. Surgical margins and additional testing are also mentioned.
Non-melanoma skin cancer
Non-melanoma skin cancer is the most common cancer in the US. The two main types are basal cell carcinoma (BCC) and squamous cell carcinoma (SCC). Risk factors include ultraviolet radiation exposure and fair skin. BCC typically occurs on sun exposed areas and is locally destructive but rarely spreads. SCC also occurs on sun exposed skin and has a greater risk of spreading. Treatment options depend on the type and location of the cancer, and may include surgery, Mohs surgery, radiation, or topical medications.
Skin Cancer
This document discusses the treatment of common skin cancers. It describes benign and premalignant skin lesions as well as the three main types of malignant skin cancer - basal cell carcinoma, squamous cell carcinoma, and melanoma. It provides details on risk factors, clinical presentation, diagnosis, staging, and treatment options for each type of skin cancer.
More Related Content
What's hot
Skin Cancer
Property of Prof. Dr. Mohamed Ali Nasr, Department of General Surgery, Faculty of Medicine, University of Zagazig, Egypt
Melanoma
This document provides information on malignant melanoma. Some key points:
- Melanoma is a malignancy of melanocytes that can occur in skin, eyes, and mucous membranes. It has a high ability to metastasize to other organs.
- Incidence is increasing worldwide. Risk factors include fair skin, moles, UV exposure, and family history.
- Diagnosis involves examining lesions for characteristics like asymmetry, irregular borders, varied color, and size over 6mm. Biopsies are used to confirm.
- Staging uses the TNM system and considers tumor thickness, ulceration, and lymph node/distant organ involvement. Prognosis depends on stage - thicker tumors over 2mm
Melanoma presentation
Melanoma is the sixth most common cancer in the US, with 68,000 new cases diagnosed each year and 8,700 annual deaths. Risk factors include fair skin, light eyes, family history, and sun exposure. Melanoma has been recognized as a disease since 1806 and stages range from Stage 0 precancerous lesions to Stage IV metastatic cancer. Treatment options depend on the stage and may include surgery, radiation, immunotherapy, and experimental therapies.
Melanoma
Melanoma is the most serious type of skin cancer. Often the first sign of melanoma is a change in the size, shape, color or feel of a mole. Most melanomas have a black or black-blue area. Melanoma may also appear as a new mole. It may be black, abnormal or "ugly looking."
Thinking of "ABCD" can help you remember what to watch for:
Asymmetry - the shape of one half does not match the other
Border - the edges are ragged, blurred or irregular
Color - the color is uneven and may include shades of black, brown and tan
Diameter - there is a change in size, usually an increase
Melanoma can be cured if it is diagnosed and treated early. If melanoma is not removed in its early stages, cancer cells may grow downward from the skin surface and invade healthy tissue. If it spreads to other parts of the body it can be difficult to control.
Melanoma
This document discusses melanoma, the most fatal form of skin cancer. It covers the incidence and risk factors of melanoma including genetics, sun exposure, and skin phenotype. The clinical features and subtypes of melanoma like superficial spreading, nodular, lentigo maligna, and acral lentiginous melanoma are described. Diagnosis involves methods like the ABCDE rule and biopsy for suspicious lesions. Staging uses the TNM system and prognostic factors include tumor thickness and mitotic rate. Management involves wide local excision of primary tumors and sentinel lymph node biopsy for involved nodes. Long term surveillance after treatment monitors for recurrence.
4part2
This document summarizes diagnosis and management of various skin cancers and pigmented lesions. It discusses diagnosis and treatment options for basal cell carcinoma, squamous cell carcinoma, melanoma, and other skin tumors. Photodynamic therapy is described as an 80% effective treatment for superficial basal cell carcinoma. Metastatic rates for squamous cell carcinoma are provided based on literature reviews. Risk factors and treatment guidelines are outlined for melanoma depending on depth of invasion and presence of metastases. Differential diagnoses are also reviewed for problematic pigmented lesions and melanomas.
Melanoma Prevention, Screening and Diagnosis - Dr. Ana Ciurea
Dr. Ana Ciurea presents the basics of melanoma preventio, screening and diagnosis at the MRF's Patient Symposium at MD Anderson Cancer Center on January 31, 2015.
Melanoma: how to detect skin cancer
Simple and fast way to detect skin cancer, melanoma.
What is cancer? Types of skin cancer, the ABCDE rule, treatment, preventing. by Daniel Lopes
Melanoma sign symptom management surgery prevention ملانوم
Melanoma sign symptom management surgery prevention ملانوم
درمان
جراحی
پیشگیری
پوست
تابش آفتاب
sun exposure
Melanoma
This document summarizes melanoma, a type of skin cancer. It originates from melanocytes in the skin or mucosal surfaces. Melanoma is more common and dangerous in white people and younger women. The main risk factor is ultraviolet radiation from the sun or tanning beds. There are four main types of melanoma named after their appearance or location on the skin. Doctors diagnose melanoma through history, physical exam, and biopsy. It is staged based on how deep it has penetrated the skin and if it has spread. Treatment options range from surgery for early stages to immunotherapy and chemotherapy for later stages.
Melanoma
- Melanoma is a malignant tumor arising from melanocytes that produces melanin. It is more common in whites due to higher UV exposure and occurs most often on head/neck, trunk and limbs. Risk factors include fair skin, moles, family history and sun exposure.
- There are several clinical types including superficial spreading, nodular, lentigo maligna, acral and amelanotic melanomas. Staging uses Breslow thickness, Clark levels, and TNM classification. Diagnosis involves biopsy and imaging tests.
- Treatment depends on stage and includes surgery, lymph node dissection, chemotherapy, immunotherapy and radiation. Prognosis is best for early stage disease and worse for advanced stages
Melanoma
This document provides information about melanoma, a serious type of skin cancer. It defines melanoma as cancer of the melanocytes, which are cells that produce skin pigment. Risk factors include family history, many moles, sunburn, and fair skin. Signs include changes in existing moles or new abnormal growths. The stages are described from earliest (stage 0) to latest (stage IV), with treatment options at each stage. Prevention focuses on sun protection and avoiding sun exposure when UV rays are strongest.
Melanoma
This document summarizes key information about melanoma. It discusses the increasing incidence rates of melanoma and describes the different types, including superficial spreading, nodular, lentigo maligna, and acral lentiginous. Prognostic factors like Breslow thickness, ulceration, location, and gender are covered. Treatment options are outlined, including surgical excision for early-stage melanoma and immunotherapy or chemotherapy for advanced or metastatic disease. Future treatments under investigation include vaccines, monoclonal antibodies, and radiation therapy.
Oral cancer
This document summarizes key information about oral cancer:
1) Oral cancer is a major malignancy in the Indian subcontinent, affecting males over 60 years old at a higher rate. Risk factors include smoking, alcohol, betel nut and spice chewing.
2) Premalignant lesions like leukoplakia and erythroplakia are associated with increased risk of oral cancer. Conditions like submucous fibrosis from betel chewing can also progress to oral squamous cell carcinoma.
3) Patient workup for oral cancer involves history, clinical exam, biopsy or FNAC of suspicious lesions, and imaging tests. Staging follows AJCC guidelines and helps determine prognosis and guide treatment.
Melanoma
Melanoma is the 5th and 6th most common malignancy in men and women respectively. It accounts for a disproportionate number of skin cancer deaths. Risk factors include family history, fair skin, intermittent sun exposure, and dysplastic nevi. Melanomas arise from melanocytes and can present in different clinical subtypes depending on their location and growth pattern. Prognosis depends on tumor thickness, ulceration status, mitotic rate, and presence of metastases. Treatment involves surgical excision with margins and possible lymph node evaluation and adjuvant therapy for advanced cases. Lifelong surveillance is important due to the risk of recurrence even decades later.
Melanoma
Melanoma is a malignant skin cancer that develops from pigment-producing cells called melanocytes. It accounts for only 1% of skin cancers but causes the majority of skin cancer deaths. Risk factors include sun exposure, the use of tanning beds, and family history. Genetic mutations in genes like BRAF, NRAS, and CDKN2A contribute to melanoma development and progression. Different types of melanoma exist including superficial spreading, nodular, lentigo maligna, acral lentiginous, and ocular/mucosal melanoma. Staging uses the Clark level and Breslow thickness scales. Treatment depends on stage but may include surgery, immunotherapy, targeted therapy, and chemotherapy. Prevention involves sun protection
Malignant melanoma
Melanoma is a serious form of skin cancer that arises in melanocytes, which are skin cells that produce melanin. It is caused by exposure to UV radiation from the sun in most cases. There are several stages of melanoma based on how deep it has penetrated the skin and whether it has spread to lymph nodes or distant organs. Early stage melanoma can usually be cured with surgery, while later stages may require additional treatments like chemotherapy. Prevention through sun protection and skin self-examinations is important to detect melanoma early.
Fwd: Skin Cancer (Cormac Joyce)
---------- Forwarded message ----------
From: UCD Graduate '09 None <ucdgrad09@gmail.com>
Date: 2009/2/25
Subject: Skin Cancer (Cormac Joyce)
To: ucdgrad09@gmail.com
Squamous cell carcinoma
Squamous cell carcinoma (SCC) is a type of skin cancer that develops in squamous cells, which make up the outer layer of the skin. SCCs often appear as scaly red patches or elevated growths and are caused by cumulative lifetime sun exposure. Risk factors include light skin, age, male gender, and sun or chemical exposure. SCCs are most common on sun-exposed areas like the face and neck and are usually treated by removing the lesion, though advanced cases may require surgery, radiation, or chemotherapy. Maintaining good oral hygiene is important for preventing complications from oral SCCs and their treatment.
Melanoma1
This document discusses melanoma, including risk factors like sun exposure and tanning beds. It covers the staging of melanoma from Stage 0 to Stage 4 and treatments that may be used like surgery, sentinel node biopsy, interferon, Yervoy, and Zelboraf. Surgical margins and additional testing are also mentioned.
What's hot (20)
Melanoma Prevention, Screening and Diagnosis - Dr. Ana Ciurea
Melanoma Prevention, Screening and Diagnosis - Dr. Ana Ciurea
Melanoma sign symptom management surgery prevention ملانوم
Melanoma sign symptom management surgery prevention ملانوم
Similar to Treating your Skin cancer - pt -update
Non-melanoma skin cancer
Non-melanoma skin cancer is the most common cancer in the US. The two main types are basal cell carcinoma (BCC) and squamous cell carcinoma (SCC). Risk factors include ultraviolet radiation exposure and fair skin. BCC typically occurs on sun exposed areas and is locally destructive but rarely spreads. SCC also occurs on sun exposed skin and has a greater risk of spreading. Treatment options depend on the type and location of the cancer, and may include surgery, Mohs surgery, radiation, or topical medications.
Skin Cancer
This document discusses the treatment of common skin cancers. It describes benign and premalignant skin lesions as well as the three main types of malignant skin cancer - basal cell carcinoma, squamous cell carcinoma, and melanoma. It provides details on risk factors, clinical presentation, diagnosis, staging, and treatment options for each type of skin cancer.
DCIS Breast Cancer
1) Ductal carcinoma in situ (DCIS), also known as stage 0 breast cancer, accounts for 20% of breast cancers in the US and represents the earliest non-invasive form.
2) Treatment options for DCIS include lumpectomy with or without radiation or total mastectomy. Factors such as tumor size, grade, and margin status help determine a patient's risk of recurrence and guide treatment decisions.
3) Short term side effects of breast radiation for DCIS typically include skin irritation, breast tenderness, and fatigue. Long term risks are generally low but may include lymphedema, lung inflammation, and fibrosis. Radiation reduces the risk of local recurrence by 50% compared to lumpectomy alone
Malignant fibrous histiocytoma, Undifferntiated pleomorphic sarcoma
Malignant fibrous histiocytoma (MFH), became Undifferntiated pleomorphic sarcoma UPS after 2002 WHO classification of tumors
malignant skin lesions /BASIC MEDICAL KNWOLEDGE .ppt
This document provides information about three types of malignant skin diseases: basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and malignant melanoma (MM). BCC is the most common type of skin cancer, usually appearing as a pearly nodule on sun-exposed areas. SCC is the second most common, associated with cumulative sun exposure and chronic inflammation. MM is less common but more deadly, with risk factors including past skin cancers, dysplastic nevi, red hair, and sunburn history. Surgical excision is the main treatment for all three, with Mohs surgery used for minimizing recurrence of BCC. Prognosis depends on factors like tumor depth, location, and presence of immunosuppression.
Head and Neck Melanoma
A presentation created by Dr. Henry N. Ho, Medical Director, Head and Neck Program, Florida Hospital Cancer Institute, discussing everything you need to know about head and neck melanoma.
Skin Cancer And The Lower Limb
This document provides an overview of several types of skin cancers that can occur on the lower limbs, including basal cell carcinoma, squamous cell carcinoma, Bowen's disease, and malignant melanoma. It discusses the characteristics, incidence, clinical features, and typical treatment approaches for each type of cancer. The risks of incomplete excision of skin cancers are also mentioned. Images are included showing examples of different skin cancers.
Ewing’s sarcoma
Ewing's sarcoma is a rare type of cancer that develops in bone or soft tissue. It is the second most common primary bone cancer in children and adolescents between 10-20 years old. The cancer presents with local swelling and tenderness at the affected site, most commonly the diaphysis of long bones. Metastasis is often present at diagnosis, with the lungs being the most common site. Diagnosis is confirmed through histopathological or cytogenetic testing. Treatment involves neoadjuvant chemotherapy followed by local tumor control through surgery or radiation therapy, along with adjuvant chemotherapy. Five-year survival rates have improved to around 70% with current multi-agent chemotherapy regimens.
Oral cancer
This document discusses oral cancer, including its causes, symptoms, diagnosis, staging, and treatment options. It notes that oral cancer is the 5th most common cancer in men and 7th most common in women, with over 400,000 new cases per year globally. The main risk factors are tobacco and alcohol use. Diagnosis involves visual examination, biopsy, and imaging tests. Treatment may involve surgery, radiation therapy, chemotherapy, or a combination, depending on the cancer's stage and location. The document provides details on each of these therapeutic approaches.
Tumours of external and middle ear
This document discusses tumours of the ear, including both benign and malignant types. It provides details on the epidemiology, risk factors, pathology, diagnosis and treatment of various tumours such as basal cell carcinoma, squamous cell carcinoma, melanoma, and others. Treatment options discussed include surgical excision with various techniques depending on tumour size and location, Mohs surgery, radiation therapy, and reconstruction after tumour removal. Staging criteria and classifications of temporal bone tumours are also presented.
ROLE OF RADIATION IN BONE TUMORS FOR ORTHOPEDICS
This document discusses soft tissue sarcomas. It begins by listing various histologic diagnoses of soft tissue sarcomas categorized by tissue of origin. It then discusses imaging with MRI and CT to evaluate tumors. Key points regarding surgery include performing limb-sparing over amputation when possible and obtaining negative margins of at least 2cm if no post-op radiation is planned. Adjuvant radiation improves local control but not necessarily survival. Pre-op radiation may increase wound complications compared to post-op.
Soft tissue tumor
This document provides information about soft tissue tumors. It discusses the epidemiology, classification, etiology, diagnosis and treatment of both benign and malignant soft tissue tumors. Some key points include:
- Benign soft tissue tumors are more common than sarcomas. Common benign tumors include lipomas, schwannomas and giant cell tumors of the tendon sheath.
- Risk factors for soft tissue sarcoma include exposure to herbicides/pesticides, radiation exposure, genetic conditions and viral infections.
- MRI is usually the best imaging modality for evaluating soft tissue tumors. Biopsy is needed for diagnosis.
- Treatment depends on whether the tumor is benign or malignant. Benign tumors may
Ca Tongue
1) Advanced lesions of cancer of the oral tongue are best managed with a combination of surgery and radiation.
2) The 5-year survival rate for oral tongue cancer is less than 50%, and a key to better survival is early detection and treatment.
3) The management of oral tongue cancer involves tailoring treatment based on the stage of cancer, with smaller early-stage cancers treated with either radiation or surgery, and larger cancers treated with a combination of both.
High beam global head and neck cancer ppt
Head and neck cancer refers to cancers that develop in the throat, mouth, sinuses, and lymph nodes in the neck. The most common type is squamous cell carcinoma, which arises in the lining of the mouth, nose and throat. Staging involves determining if the cancer is localized, regional (spread to lymph nodes), or distant (metastasized). Treatment depends on the stage and location but may include surgery, radiation therapy, chemotherapy, and rehabilitation. Regular follow-up is important after treatment to monitor for recurrence or new cancers.
Head and Neck Cancer
Head and neck cancer refers to cancers that develop in the throat, mouth, sinuses, and lymph nodes in the neck. The most common type is squamous cell carcinoma, which arises in the lining of the mouth, nose and throat. Staging involves determining if the cancer is localized, regional (spread to lymph nodes), or distant (metastasized). Treatment depends on the stage and location but may include surgery, radiation therapy, chemotherapy, and rehabilitation. Regular follow-up is important after treatment to monitor for recurrence or new cancers.
Orthopaedic oncology
Dr. Ledian Fezollari's document discusses bone tumors. It begins by stating that primary malignant bone tumors make up 1% of all cancers and the most common bone tumor is metastases from other sites. The WHO classification of bone tumors is mentioned. Clinical presentation depends on age, with most benign tumors in children and myeloma most common over age 70. Investigations include imaging like radiography, CT, MRI, and biopsy. Treatment depends on tumor type and stage, and may involve chemotherapy, surgery such as limb salvage or amputation, and radiotherapy.
Bone tumors
Dr. Ledian Fezollari discusses bone tumors in a document covering their classification, clinical presentation, investigations and treatment. Some key points:
- Primary malignant bone tumors make up 1% of all cancers but secondary bone tumors from other sites are more common.
- Presentation depends on age, with childhood cancers like osteosarcoma and Ewing's sarcoma more common. Myeloma is the most common bone tumor in those over 70.
- Investigations include imaging like x-rays, CT and MRI to determine location and extent of the tumor. Biopsies are also important.
- Treatment depends on tumor type and stage but may include chemotherapy, surgery like limb salvage procedures
Oncology
This document discusses principles of cancer therapy and different treatment modalities, including surgery, radiation therapy, and chemotherapy. It provides details on each treatment type, how they work to target cancer cells, their goals and side effects. The key points are:
1) The main treatment modalities are surgery, radiation therapy, chemotherapy and immunotherapy. Each aims to eliminate cancer cells while limiting harm to healthy tissue.
2) Surgery aims to entirely remove the cancer, but recurrence is possible if microscopic cells remain. Radiation therapy damages DNA in cancer cells to stop growth and division.
3) While treatments aim to cure, controlling symptoms and improving quality of life are also important goals, as curing all cancers is unlikely
Dr Patrick Treacy on Diagnosis and Treatment of Malignant Melanoma
A 23-year-old Siberian female patient presented with a changing lesion on her abdomen. The patient stated the lesion was present for about two years and it started
off from within a freckle, which started to grow larger and somewhat darken in appearance. It had the clinical appearance of a melanoma and the dermoscopy three-point checklist (designed to allow non-experts not to miss detection of melanomas) was used to determine whether this had a high likelihood of malignancy. It included:
Asymmetry: asymmetry of colour and structure in one or
two perpendicular axes
Atypical network: pigment network with irregular holes
and thick lines
Blue-white structures: there was some evidence of blue-
white veil and regression structures
Similar to Treating your Skin cancer - pt -update (20)
Malignant fibrous histiocytoma, Undifferntiated pleomorphic sarcoma
Malignant fibrous histiocytoma, Undifferntiated pleomorphic sarcoma
malignant skin lesions /BASIC MEDICAL KNWOLEDGE .ppt
malignant skin lesions /BASIC MEDICAL KNWOLEDGE .ppt
Dr Patrick Treacy on Diagnosis and Treatment of Malignant Melanoma
Dr Patrick Treacy on Diagnosis and Treatment of Malignant Melanoma
Treating your Skin cancer - pt -update
- 1. A N D R E W S T Y P E R E K M D Treating your Skin cancer TAMARAC 7301 N University Drive, Suite 102 Tamarac, FL 33321 Phone: 954-726-2000
- 2. Basal Cell Carcinoma (BCC)
- 3. Quick Facts #1 cancer in America, ~ 2M cases annually No precursor lesion Aggressive and Non-aggressive subtypes Local destructive growth Metastasis: < 1/1000
- 5. Quick Facts #2 cancer, ~ 1M cases annually Precursor lesions for most types of SCC Lifetime risk of SCC if have pre-cancers: 6-10% Aggressive and Non-aggressive subtypes Local destructive growth which may track along nerves Metastasis: < 5%, up to 30% on lip or genitals Related to depth, location, immunosuppression
- 6. Don’t let garden weeds become kudzu
- 7. Mohs: Choosing the best for your family Certainty of removal Patient: Convenient & Fast Medical: No lesion follow-up. Cost effective. Minimize tissue removal Certainty allows you to take smaller margins Important for vital structures (nose, ears, eyelids, lips, etc.)
- 9. Non-surgical treatments offered by many dermatologists can lead to bigger problems 7cm 14cm Initial Lesion Mohs treated Lesion (20 yrs later)
- 10. The miMOHS™ experience Minimal pain injections We offer topical numbing cream to apply at home Patient and gentle techniques to avoid the “stick and sting” Creating a comfortable environment Friendly staff, relaxed atmosphere Bottle water and coffee, relaxing music, private waiting area Subtle & sophisticated: Taking less tissue without compromising certainty Minimize surgical injury Minimal cautery smoke Simpler closures when possible, speeding post-operative healing Instructions & Medications to treat residual pain post-procedure Antibiotics to prevent infection A personal emergency contact number A follow-up call to ensure comfort Scar revision Chemical peel, dermabraision, or laser scar treatment
- 11. Not every tumor is the same… Some are shallow
- 12. Which would you prefer? Shallow or Deep? Vs. miMOHS™ traditional MOHS
- 13. Some tumors are deep
- 14. If the tumor is deep, we treat that too.
- 15. Melanoma in situ
- 16. Quick facts Melanoma is #4 diagnosed cancer, ~ 74K in 2015 In-situ is #1 stage diagnosed, ~ 64K in 2015 Indolent (in elderly) vs. early aggressive tumor types 5-10 year survival ~ 99-100% Very low risk of metastasis Treated with excision only
- 17. Treating your Melanoma in situ Excision of 5-10 mm margins Similar drawbacks as for BCC/SCC excision Mohs with IHC Total margin control of Mohs + immunohistochemical stains (MART-1) to track and identify positive margins at the time of excision 577 pt study, avg f/u 2.8 yrs: < 0.5% recurrence
- 18. MART-1 Stain Using special stains, we track the melanoma tumor to ensure the tumor is out and the least tissue is sacrificed.